| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/17/2001 | EP1068212A1 THIAZOLO 4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS |
| 01/17/2001 | EP1068208A1 Azatricyclo[3.3.1.1] decane derivatives and pharmaceutical compositions containing them |
| 01/17/2001 | EP1068207A1 AMINOALKYL SUBSTITUTED 9H-PYRIDINO 2,3-b]INDOLE AND 9H-PYRIMIDINO 4,5-b]INDOLE DERIVATIVES |
| 01/17/2001 | EP1068206A1 Aminoalkyl substituted pyrrolo 2,3-b]pyridine and pyrrolo 2,3-d]pyrimidine derivatives: modulators of crf1 receptors |
| 01/17/2001 | EP1068202A1 1-(3-heteroarylpropyl- or -prop-2-enyl)-4-benzylpiperidines used as nmda receptor antagonists |
| 01/17/2001 | EP1068198A1 5-heteroaryl substituted indoles |
| 01/17/2001 | EP1068195A1 Antagonists of gonadotropin releasing hormone |
| 01/17/2001 | EP1068194A1 Pde iv inhibiting pyridine derivatives |
| 01/17/2001 | EP1068193A1 Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d 4? receptor antagonists |
| 01/17/2001 | EP1068191A1 Benzoxazinones/benzothiazinones as serine protease inhibitors |
| 01/17/2001 | EP1068190A1 Quinoxalinones as serine protease inhibitors such as factor xa and thrombin |
| 01/17/2001 | EP1068189A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors |
| 01/17/2001 | EP1068187A1 Pyrazole inhibitors of cytokine production |
| 01/17/2001 | EP1068186A2 Pharmaceutical compositions and methods for use |
| 01/17/2001 | EP1068185A1 Compounds with activity on muscarinic receptors |
| 01/17/2001 | EP1068180A1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors |
| 01/17/2001 | EP1068178A1 NON-PEPTIDE GnRH AGENTS |
| 01/17/2001 | EP1067965A1 Pharmaceutical composition for treating cerebral apoplexy and craniocerebral trauma |
| 01/17/2001 | EP1067963A1 Hiv-specific cytotoxic t-cell responses |
| 01/17/2001 | EP1067959A2 Use of igf1 for treating articular cartilage disorders |
| 01/17/2001 | EP1067958A2 Treatment of cardiac hypertrophy |
| 01/17/2001 | EP1067954A1 USE OF ANTI-gp39 ANTIBODIES FOR TREATMENT AND/OR REVERSAL OF LUPUS AND ASSOCIATED KIDNEY DISEASE |
| 01/17/2001 | EP1067941A1 Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate |
| 01/17/2001 | EP1067940A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 01/17/2001 | EP1067939A1 Use of steroidal alkaloid derivatives as inhibitors of hedgehog signaling pathways |
| 01/17/2001 | EP1067935A1 Acylbenzoxazines for enhancing synaptic response(s) |
| 01/17/2001 | EP1067932A1 Methods for inhibiting mrp1 |
| 01/17/2001 | EP1067928A1 Methods for inhibiting mrp1 |
| 01/17/2001 | EP1067926A2 Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins |
| 01/17/2001 | EP1067920A1 Methods and compositions for reducing uv-induced inhibition of collagen synthesis in human skin |
| 01/17/2001 | EP1067917A2 Method of treating dopaminergic and gaba-nergic disorders |
| 01/17/2001 | EP1067911A1 Hydrogel compositions useful for the sustained release of macromolecules and methods of making same |
| 01/17/2001 | EP1067894A2 Protease inhibitors |
| 01/17/2001 | EP1067893A2 Human galactosyl transferases |
| 01/17/2001 | EP1067838A1 Treatment of respiratory disease and otitis media |
| 01/17/2001 | EP0983258A4 N-hydroxy 4-sulfonyl butanamide compounds |
| 01/17/2001 | EP0786991B1 Polyamine compounds for treating vascular proliferative disorders |
| 01/17/2001 | EP0730590B1 isoxazoline and isoxazole fibrinogen receptor antagonists |
| 01/17/2001 | EP0490919B1 Cytoprotective compounds bearing unsaturated hydrocarbon groups having 16 to 20 carbon atoms |
| 01/17/2001 | CN1280613A Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor |
| 01/17/2001 | CN1280586A Erythropoietin with high specific activity |
| 01/17/2001 | CN1280579A Novel polymorphic forms of cipamfylline |
| 01/17/2001 | CN1280577A Benzodioxan, benzofuran or benzopyranl derivatives having fundic relaxation properties |
| 01/17/2001 | CN1280572A Inhibiting platelet derivative growth factor and/or quinoline and quinowoline compounds of P56lek tyrosinkinase |
| 01/17/2001 | CN1280568A Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 01/17/2001 | CN1280503A Method of mobilizing hematopoietic stem cells |
| 01/17/2001 | CN1280006A Medicine ointment prepared with kapur and other Chinese herbal medicine |
| 01/17/2001 | CN1279984A Fish medicine for preventing fish from raising nose above water |
| 01/17/2001 | CN1279973A Growth promoter for children |
| 01/17/2001 | CN1279971A Capsule for curing hydrocephalus and its producing method |
| 01/17/2001 | CN1279950A Sigma-receptor acting medicine with triterpene compound structure |
| 01/17/2001 | CN1279939A Local use cosmetic compositions containing benzaldoximes compounds |
| 01/17/2001 | CN1060781C Phosphonomonoester nucleic acids, process for treir preparation, and their use |
| 01/17/2001 | CN1060775C Fused troane-derivatives as neurotransmitter reuptake inhibitors |
| 01/17/2001 | CN1060774C Process for preparation of enantionerically pure imidazolyl compounds |
| 01/17/2001 | CN1060772C New Indole, Indazole and benzisoxazole compounds, their process of preparation and pharmaceutical compositions which contain them |
| 01/17/2001 | CN1060764C Ortho-substituted benzoylguanidine, preparation method, use as medicine or diagnostic reagent and medicine containing them |
| 01/17/2001 | CN1060763C Urea-substituted benzoylguanidines, process for their preparation, and use and pharmaceutical containing them |
| 01/17/2001 | CN1060679C Use of combination of angiotensin-converting enzyme inhibitor and calcium antagonist for treatment of proteinuria |
| 01/17/2001 | CN1060661C Tonic wine capable of protecting kidney and strengthening bone |
| 01/16/2001 | US6175021 Human non-pancreatic secretory phospholipase a2 (spla2); inhibits release of arachidonic acid to treat septic shock; ((3-(2-amino-1,2-dioxoethyl)-2-methyl-1-(phenylmethyl)-1h-indol-4 -yl)oxylacetic acid, for example |
| 01/16/2001 | US6175013 1-(2-methoxybenzyl)-2-((4-phenyl-1-piperazinyl)methyl)-4-(1h -indol-3-ylmethyl)-2-imidazoline, for example; adminstering to treat anxiety, depression, psychosis, and schizophrenia |
| 01/16/2001 | US6174994 7TM receptor (H2CAA71) |
| 01/16/2001 | US6174993 Short peptides which selectively modulate the activity of serine/threonine kinases |
| 01/16/2001 | US6174924 Treating nerve cell death comprising administering to a subject exhibiting symptoms of nerve cell death or susceptible to nerve cell death a substituted guanidine compound |
| 01/16/2001 | US6174910 Treating pathological symptoms of vascular proliferation disorders which can be reduced or inhibited by apoptosis, by administering at.sub.1(angiotensin) receptor antagonist compound such as valsartan, irbesartan, losatran etc. |
| 01/16/2001 | US6174904 Treating glycometabolism disorders in mammals by administering therapeutically effective amount of an insulin sensitivity enhancer in combination with an .alpha.-glucosidase inhibitor |
| 01/16/2001 | US6174896 Quinuclidine derivatives and medicinal composition thereof |
| 01/16/2001 | US6174895 1-aryl-3-arylmethyl-1,8-naphthyridin-4(1H)-ones |
| 01/16/2001 | US6174890 A synergistic biological, neurometabolic and celltrophic composition comprising antioxidative and -catabolic stress (methionine),-anabolic drugs, vasodilative and normo-lipidemic drugs (nicotinic acid), energoactive and antitoxic |
| 01/16/2001 | US6174889 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/16/2001 | US6174887 Amide compounds and use of the same |
| 01/16/2001 | US6174883 3-substituted-2-oxindoles derivatives |
| 01/16/2001 | US6174874 Phosphonic acids derivatives as inhibitors of protein tyrosine phosphate 1B (PTP-1B) |
| 01/16/2001 | US6174869 Method for enhancing neurone survival and agents useful for same |
| 01/16/2001 | US6174863 Carbohydrate derivatives |
| 01/16/2001 | US6174862 Neuroprotectant administered to patients suffering from alzheimer's disease, human immunodeficiency virus |
| 01/16/2001 | US6174857 Parenteral mixture comprising insulin-like growth factor i, a bone antiresorptive compound and a carrier |
| 01/16/2001 | US6174714 Lyss |
| 01/16/2001 | US6174534 Mixture containing fatty acid, ester of polyalkylene ether, hydrogenated palm oil and polyoxyethylenated hydrogenated palm kernel oil, fatty ester, glycerol, fatty alcohol and water |
| 01/16/2001 | US6174531 Methods of preparation of bioginkgo |
| 01/16/2001 | CA2314008A1 2-benzimidazolylamine compounds as orl1-receptor agonists |
| 01/16/2001 | CA2204355C Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 01/16/2001 | CA2200192C Amidino and guanidino substituted inhibitors of trypsin-like enzymes |
| 01/16/2001 | CA2198099C Use of tasteless, hydrolysed collagen and agent containing the same |
| 01/16/2001 | CA2150234E Combination of atovaquone with proguanil for the treatment of protozoal infections |
| 01/16/2001 | CA2068324C Metal-peptide compositions and methods for stimulating hair growth |
| 01/16/2001 | CA2021954C Substituted triazolinones, triazolinethiones and triazolinimines as angiotensin ii antagonists |
| 01/14/2001 | CA2277407A1 Pharmaceutical tablet comprising an nsaid and misoprostol |
| 01/11/2001 | WO2001081364A1 Estra-1,3,5(10)-triene derivatives |
| 01/11/2001 | WO2001002604A1 Use of the krit1 gene in angiogenesis |
| 01/11/2001 | WO2001002598A2 Screening for compounds modulating mitochondrial proton leak |
| 01/11/2001 | WO2001002594A2 DNA CONSTRUCTS BASED ON THE eIF4A GENE PROMOTER |
| 01/11/2001 | WO2001002569A2 Human immune response molecules |
| 01/11/2001 | WO2001002561A2 Mammalian calcium channels and related probes, cell lines and methods |
| 01/11/2001 | WO2001002559A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 01/11/2001 | WO2001002557A1 Neurotrophic factor receptor |
| 01/11/2001 | WO2001002551A2 Virus like particles, preparation and use in screening and functional genomics |
| 01/11/2001 | WO2001002550A2 Cell death related drug targets in yeast and fungi |
| 01/11/2001 | WO2001002540A2 Adenoviral vectors for treating disease |